Mathematics
Angiotensin
100%
Congestive Heart Failure
89%
Cohort Study
68%
Inhibitor
66%
Enzymes
63%
Stratification
57%
Gene
20%
Single nucleotide Polymorphism
15%
Incidence
15%
Receptor
13%
Bradykinin
10%
Echocardiography
9%
Angiotensin II
9%
Ischemic Heart Disease
9%
Hypertension
8%
Proportional Hazards
6%
Blood
5%
Heart
5%
Efficacy
5%
Predict
4%
Background
4%
Evidence
4%
Estimator
3%
Agriculture & Biology
pharmacogenomics
81%
angiotensin-converting enzyme inhibitors
75%
heart failure
73%
cohort studies
72%
death
40%
incidence
18%
single nucleotide polymorphism
16%
echocardiography
13%
genes
12%
receptors
11%
myocardial ischemia
11%
bradykinin
10%
peptidyl-dipeptidase A
10%
blood groups
10%
angiotensin II
10%
hypertension
9%
heart
6%
methodology
2%
Medicine & Life Sciences
Pharmacogenetics
60%
Angiotensin-Converting Enzyme Inhibitors
52%
Heart Failure
38%
Cohort Studies
36%
Retrospective Studies
35%
Cause of Death
25%
Single Nucleotide Polymorphism
17%
Bradykinin B1 Receptors
17%
Genes
17%
Incidence
15%
Angiotensin Type 1 Receptor
13%
Fatal Outcome
12%
Peptidyl-Dipeptidase A
11%
Blood Group Antigens
11%
Myocardial Ischemia
9%
Echocardiography
8%
Health Care Outcome Assessment
6%
Hypertension
6%
Heart
6%
Survival
5%
Therapeutics
1%
Engineering & Materials Science
Pharmacogenetics
91%
Enzymes
60%
Genes
40%
Polymorphism
26%
Nucleotides
26%
Bradykinin
23%
Echocardiography
15%
Blood
9%
Hazards
9%
Earth & Environmental Sciences
inhibitor
49%
stratification
44%
enzyme
42%
gene
32%
polymorphism
22%
hypertension
13%
cardiovascular disease
12%
blood
8%
hazard
7%
method
2%